Takeaway: Single protein discovery could unlock CAR-T cell therapy’s full potential

GMJ
By
Prof. Giorgi Pkhakadze
0 Min Read
Scientific illustration showing CAR-T cells attacking cancer with molecular pathway highlighted
Researchers identify NFIL3 protein as key barrier to CAR-T cell therapy success. Disabling this protein maintained stronger cancer-fighting activity in preclinical models. — Photo: turek / Pexels
1 min read|30 words

🔬 3 key takeaways from new CAR-T research: 1️⃣ NFIL3 protein causes CAR-T cell exhaustion 2️⃣ Disabling it maintained stronger cancer-fighting activity 3️⃣ Could lead to more durable immunotherapies

Read the full article on GMJ Newsroom →

Was this article helpful?

Share This Article
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Trump Administration Removes Job Protections for Thousands of Federal Health Workers

Thousands of federal health workers at HHS agencies including CDC, FDA, and…

Rare Lymphatic-Urinary Fistula Causes Milky Urine in NEJM Case Report

A rare case of chyluria caused by a lymphatic-urinary fistula demonstrates how…

Gene Therapy Shows Promise for Inherited Cholesterol Disorder in First-in-Human Trial

First-in-human gene therapy trial shows preliminary safety and efficacy for treating homozygous…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like